EU Regulation of Medical Devices and Pharmaceuticals in Comparative Perspective

Christa Altenstetter and Govin Permanand

Review of Policy Research, 2007, vol. 24, issue 5, 385-405

Abstract: This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical devices. The discussion highlights key similarities and differences in regulatory approach for the two sectors. More importantly, it explores the balance that has been struck between public health, health care, and industrial policy as “competing” objectives within the respective regulatory regimes. It is argued that, despite both sectors being affected by the same institutional rules and constraints at the EU level, and both being central to the delivery of high‐quality health care in Europe, there are a surprising number of differences between the regulatory frameworks. That this stems in part from their different “launch” times, hence different institutional conditions of regulation, and commensurate political climates, as well as reflecting different aims and goals among member‐state and EU‐level policy makers, are among the paper's main conclusions.

Date: 2007
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://doi.org/10.1111/j.1541-1338.2007.00291.x

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:revpol:v:24:y:2007:i:5:p:385-405

Ordering information: This journal article can be ordered from
http://www.wiley.com/bw/subs.asp?ref=1541-132x

Access Statistics for this article

Review of Policy Research is currently edited by Christopher Gore

More articles in Review of Policy Research from Policy Studies Organization Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().